Type 2 diabetes, obesity, and metabolic syndrome (hereafter referred to as “diabesity”) associated with increased insulin resistance and/or decreased insulin sensitivity have also been implicated with mitochondrial dysfunction and alterations in energy metabolism. This evidence concerns the gene INS and type 2 diabetes mellitus.